The 20 Best Homozygous Familial Hypercholesterolemia (HoFH) Doctors Near Me

Dean Kereiakes is a Cardiologist in Cincinnati, Ohio. Dr. Kereiakes is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Coronary Heart Disease, Aortic Valve Stenosis, Angina, Lithotripsy, and Percutaneous Coronary Intervention (PCI).

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Christie Ballantyne is a Cardiologist in Houston, Texas. Dr. Ballantyne has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Familial Hypertriglyceridemia, High Cholesterol, Atherosclerosis, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Sotirios Tsimikas is a Cardiologist in La Jolla,, California. Dr. Tsimikas is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Ajay J. Kirtane, MD, SM, is the Director of Columbia Interventional Cardiovascular Care and Professor of Medicine at Columbia University Irving Medical Center. He is an internationally-renowned leader in the field of Interventional Cardiology, with a particular focus on providing exceptional and evidence-based care to patients with complex coronary and peripheral vascular disease. In addition to his clinical commitments, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Division of Cardiology, and as director of several international, national, and regional educational conferences in Interventional Cardiovascular Medicine. Dr. Kirtane’s research interests are in clinical trials and outcomes of device-based and pharmacologic interventions to help patients with cardiovascular disease. He is/has been Principal Investigator and serves on the steering committees of numerous clinical trials in interventional cardiovascular medicine and has authored over 700 peer-reviewed publications.Born in Brooklyn, New York, and raised in Bergen County, New Jersey, Dr. Kirtane is a graduate of Ridgewood High School, Princeton University, and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California – San Francisco. He then completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and additionally obtained a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health prior to moving back to Columbia. In his free time, Dr. Kirtane has avid interests in music and sports, and lives in New Jersey with his family. Dr. Kirtane is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Coronary Heart Disease, Heart Attack, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Atherectomy.

Wilbert Aronow is a primary care provider, practicing in Internal Medicine in Hawthorne, New York. Dr. Aronow is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Heart Failure, Heart Attack, Hypertension, Percutaneous Coronary Intervention (PCI), and Aortic Valve Replacement.

Patrick Moriarty is a primary care provider, practicing in Internal Medicine in Kansas City, Kansas. Dr. Moriarty has been practicing medicine for over 42 years and is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), and Defective Apolipoprotein B-100. Dr. Moriarty is currently accepting new patients.

Michael Bohm practices in Homburg, Germany. Mr. Bohm is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Hypertension, Heart Failure, Peripartum Cardiomyopathy, Cardiac Ablation, and Angioplasty.

Wei Wang is a Psychiatrist in Englewood, New Jersey. Dr. Wang is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Her top areas of expertise are Gallbladder Disease, Dementia, Ocular Hypertension (OHT), Endoscopy, and Bone Marrow Aspiration. Dr. Wang is currently accepting new patients.

Hayato Tada practices in Kanazawa, Japan. Mr. Tada is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Familial Hypercholesterolemia, High Cholesterol, Sitosterolemia, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

Robert Hegele practices in London, Canada. Hegele is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Their top areas of expertise are Familial Hypertriglyceridemia, High Cholesterol, Apolipoprotein C2 Deficiency, and Familial Lipoprotein Lipase Deficiency.

Jing Zhao practices in Wuhan, China. Zhao is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Endoscopy, and Corneal Transplant.

Daniel Rader is a primary care provider, a Cardiologist and a Medical Genetics provider in Philadelphia, Pennsylvania. Dr. Rader is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), Coronary Heart Disease, and Heart Transplant. Dr. Rader is currently accepting new patients.

Masa-aki Kawashiri practices in Kaga, Japan. Mr. Kawashiri is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Familial Hypercholesterolemia, High Cholesterol, Sitosterolemia, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Raul Santos practices in Sao Paulo, Brazil. Mr. Santos is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), and Angioplasty.

Gerald Watts practices in Nedlands, Australia. Mr. Watts is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Familial Hypertriglyceridemia, and Defective Apolipoprotein B-100.

Mariko Shiba-Harada practices in Osaka, Japan. Ms. Shiba-Harada is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Her top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), High Cholesterol, Familial Hypercholesterolemia, and Homozygous Familial Hypercholesterolemia (HoFH).

Salim Virani is a primary care provider, practicing in Cardiologist in Houston, Texas. Dr. Virani is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Coronary Artery Bypass Graft (CABG), and Percutaneous Coronary Intervention (PCI).

Eric Bruckert practices in Paris, France. Mr. Bruckert is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Masakazu Yamagishi practices in Toyama, Japan. Mr. Yamagishi is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Sitosterolemia, Percutaneous Coronary Intervention (PCI), and Angioplasty.